NASDAQ:ALXN
Delisted
Alexion Pharmaceuticals Stock News
$182.50
+0 (+0%)
At Close: May 27, 2022
These Red-Hot Biotechs Are Leading The Pack And Could Be Actionable
07:30am, Tuesday, 10'th Nov 2020
The best biotech companies to invest in tend to have a commonality: a strong streak of earnings growth. The post These Red-Hot Biotechs Are Leading The Pack And Could Be Actionable appeared first on I
Alexion to Present at Upcoming Virtual Investor Conferences
07:00am, Tuesday, 10'th Nov 2020
BOSTON--(BUSINESS WIRE)--Alexion to Present at Upcoming Virtual Investor Conferences
Stock Upgrades: Alexion Pharmaceuticals Shows Rising Relative Strength
06:43pm, Thursday, 05'th Nov 2020
Alexion Pharmaceuticals sees its Relative Strength Rating enter the 80-plus level. The post Stock Upgrades: Alexion Pharmaceuticals Shows Rising Relative Strength appeared first on Investor's Business
Alexion Announces Upcoming Data Presentations at the 62nd American Society of Hematology Annual Meeting and Exposition
11:50am, Wednesday, 04'th Nov 2020
BOSTON--(BUSINESS WIRE)--Alexion Announces Upcoming Data Presentations at the 62nd American Society of Hematology Annual Meeting and Exposition
Got $1,000? 3 Explosive Stocks to Buy During a Market Crash
05:51am, Monday, 02'nd Nov 2020
A falling market represents the perfect opportunity to buy into these game-changing companies.
What's Behind Alexion's Impressive Q3 Results
02:43pm, Thursday, 29'th Oct 2020
The biotech delivered strong top- and bottom-line growth and boosted its full-year outlook.
Alexion Pharmaceuticals' (ALXN) CEO Ludwig Hantson on Q3 2020 Results - Earnings Call Transcript
02:35pm, Thursday, 29'th Oct 2020
Alexion Pharmaceuticals' (ALXN) CEO Ludwig Hantson on Q3 2020 Results - Earnings Call Transcript
Eaton Vance Exits Gilead, Alexion Pharmaceuticals
12:27pm, Thursday, 29'th Oct 2020
The Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) sold shares of the following stocks during its third quarter of fiscal 2020, which ended on Sept. 30.
Alexion (ALXN) Beats on Q3 Earnings & Sales, Ups '20 Guidance
11:30am, Thursday, 29'th Oct 2020
Alexion (ALXN) beats earnings and sales estimates in the third quarter of 2020.
Alexion Pharmaceuticals (ALXN) Q3 Earnings and Revenues Surpass Estimates
07:55am, Thursday, 29'th Oct 2020
Alexion (ALXN) delivered earnings and revenue surprises of 25.10% and 11.55%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Alexion Pharmaceuticals: Q3 Earnings Insights
07:49am, Thursday, 29'th Oct 2020
Shares of Alexion Pharmaceuticals (NASDAQ:ALXN) moved higher by 6.7% in pre-market trading after the company reported Q3 results.
Alexion Pharmaceuticals Earnings Beat, Biotech Hikes 2020 Guidance, As Promised
07:35am, Thursday, 29'th Oct 2020
Alexion Pharmaceuticals earnings and revenue easily beat Q3 views. The biotech giant also raised full-year guidance, after saying it would.
Alexion Reports Third Quarter 2020 Results
06:30am, Thursday, 29'th Oct 2020
BOSTON--(BUSINESS WIRE)--Alexion Reports Third Quarter 2020 Results
Top 5 Trades of the Eaton Vance Worldwide Health Sciences Fund
03:45pm, Wednesday, 28'th Oct 2020
The Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) disclosed its portfolio for the third quarter of the year earlier this week.
Is a Surprise Coming for Alexion (ALXN) This Earnings Season?
08:42am, Wednesday, 28'th Oct 2020
Alexion (ALXN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
